BD Launches Fully Automated, High-Throughput Infectious Disease Molecular Diagnostic Platform in the US - PR Newswire

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. launch of its new, fully...

With 510(k) clearance from the U.S. Food and Drug Administration (FDA), the new BD COR MX instrument is a new analytic instrument option for the BD COR System. The first test available on the new sys… [+3969 chars]

full article...